PMV Pharmaceuticals, Inc. (PMVP) Reports In-Line Q3 EPS

PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) reported Q3 EPS of ($0.40), in-line with the analyst estimate of ($0.40).

For earnings history and earnings-related data on PMV Pharmaceuticals, Inc. (PMVP) click here.

You May Also Be Interested In

• Tredegar Corp. (TG) Tops Q2 EPS by 18c
• ICICI Securities Upgrades Vijaya Diagnostic Centre (VIJAYA:IN) to Buy (1)
• Nomura/Instinet Upgrades ITEQ Corporation (6213:TT) to Buy